Related Experiment Videos
Biliary atresia: current management and outcome
T Muraji1, E Nishijima, Y Higashimoto
1Department of Surgery, Kobe Children's Hospital, Japan.
Insights
This study compared two corticosteroid regimens for biliary atresia (BA) patients. Repeated corticosteroid therapy in Group II significantly improved bile flow and 5-year survival rates compared to a single course in Group I.
Area of Science:
- Pediatric Surgery
- Hepatology
- Gastroenterology
Background:
- Biliary atresia (BA) is a severe neonatal liver disease requiring surgical intervention.
- Roux-Y reconstruction is a common surgical approach for BA.
- Optimizing postoperative management, including corticosteroid use, is crucial for improving outcomes.
Purpose of the Study:
- To evaluate the efficacy of a repeated corticosteroid therapy regimen compared to a single course in patients with biliary atresia.
- To assess the impact of different corticosteroid strategies on bile flow, cholangitis incidence, and long-term survival.
Main Methods:
- Retrospective analysis of 42 biliary atresia patients treated between 1986-1994.
- Patients underwent Roux-Y reconstruction; Group I received a single corticosteroid course, Group II received repeated courses based on stool color.
- Outcomes including bile flow, cholangitis, and 5-year survival were compared between groups.
Main Results:
- Group II demonstrated significantly improved bile flow (60% excellent vs. 29% in Group I).
- Five-year survival significantly increased from 70% in Group I to 96% in Group II.
- No significant difference in cholangitis incidence was observed between patients with or without an intussuscepted valve.
Conclusions:
- Repeated corticosteroid therapy is associated with improved bile flow and significantly better 5-year survival in biliary atresia patients.
- The findings suggest a beneficial role for aggressive corticosteroid management and potentially liver transplantation in improving outcomes.
- Surgical technique variations (valve vs. no valve) did not significantly impact cholangitis rates.
Abstract:
Between 1986 and 1994, 42 patients with BA were treated at the Kobe Children's Hospital. These patients underwent a wider excision of the hilar fibrous remnant with Roux-Y reconstruction (with or without intussuscepted valve) without stoma. Corticosteroids were used postoperatively when the stool was acholic or unsteadily cholic. The daily dose was reduced from 20 mg/day by half down. The patients were divided into two groups; in Group I (n = 17, before October 1990), a single course of corticosteroid therapy was employed. In Group II (n = 25, from November 1990 on), this regimen was repeated whenever the stool appeared less cholic. The bile flow improved significantly (excellent in 29% and 60%, and poor in 71% and 32% in Groups I and II, respectively.) Corticosteroids were used in 15 Group I patients with good response in 10 and in 21 Group II patients, 15 of whom had multiple courses. Sixteen of the 21 Group II patients had a good response. The incidence of the cholangitis was not significantly different between the 19 patients with valve and the 23 patients without valve. A 5 year survival significantly improved from 70% in Group I to 96% in Group II. In both groups, the survival rate significantly increased, when compared with the survival rate figured out with an assumption of OLT survivors as dead. On the same assumption, the survival rate of Group II is significantly more than that of the Group II. These suggest a positive contribution of liver transplantation and an aggressive corticosteroid therapy on better survival of Group II.